HEADER TRANSCRIPTION 17-AUG-22 8E3N TITLE CRYSTAL STRUCTURE OF PREGNANE X RECEPTOR LIGAND BINDING DOMAIN TITLE 2 COMPLEXED WITH RIFAMYCIN S COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 153-457; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, METABOLISM, ANTIBIOTIC, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.D.HUBER,S.POUDEL,J.SEETHARAMAN,D.J.MILLER,W.LIN,T.CHEN REVDAT 2 25-OCT-23 8E3N 1 REMARK REVDAT 1 15-MAR-23 8E3N 0 JRNL AUTH W.LIN,A.D.HUBER,S.POUDEL,Y.LI,J.SEETHARAMAN,D.J.MILLER, JRNL AUTH 2 T.CHEN JRNL TITL STRUCTURE-GUIDED APPROACH TO MODULATE SMALL MOLECULE BINDING JRNL TITL 2 TO A PROMISCUOUS LIGAND-ACTIVATED PROTEIN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 120 04120 2023 JRNL REFN ESSN 1091-6490 JRNL PMID 36848571 JRNL DOI 10.1073/PNAS.2217804120 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 18018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.4900 - 4.3000 1.00 2575 166 0.1977 0.2083 REMARK 3 2 4.3000 - 3.4200 1.00 2467 126 0.1916 0.2233 REMARK 3 3 3.4200 - 2.9800 1.00 2421 153 0.2240 0.2645 REMARK 3 4 2.9800 - 2.7100 1.00 2438 99 0.2208 0.2563 REMARK 3 5 2.7100 - 2.5200 1.00 2424 120 0.2264 0.2750 REMARK 3 6 2.5200 - 2.3700 1.00 2388 118 0.2386 0.2778 REMARK 3 7 2.3700 - 2.2500 1.00 2392 131 0.2347 0.2807 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.235 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2299 REMARK 3 ANGLE : 0.805 3109 REMARK 3 CHIRALITY : 0.050 341 REMARK 3 PLANARITY : 0.004 396 REMARK 3 DIHEDRAL : 16.221 870 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8E3N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267194. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22158 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 32.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : 0.09200 REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1M13 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM IMIDAZOLE (PH 7.2), 14% REMARK 280 ISOPROPANOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.99550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.94650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.94650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.49325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.94650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.94650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.49775 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.94650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.94650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.49325 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.94650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.94650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.49775 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.99550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 GLY A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 177 CG1 CG2 REMARK 470 GLN A 201 CG CD OE1 NE2 REMARK 470 LEU A 209 CG CD1 CD2 REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 GLU A 309 CG CD OE1 OE2 REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 THR A 311 OG1 CG2 REMARK 470 ARG A 360 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 209 -86.47 -68.57 REMARK 500 CYS A 301 65.60 -105.45 REMARK 500 THR A 311 71.97 -153.41 REMARK 500 ALA A 312 139.48 77.96 REMARK 500 PHE A 349 54.12 -91.61 REMARK 500 PHE A 420 -28.94 -154.87 REMARK 500 REMARK 500 REMARK: NULL DBREF 8E3N A 130 434 UNP O75469 NR1I2_HUMAN 153 457 SEQADV 8E3N MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 8E3N GLY A 120 UNP O75469 EXPRESSION TAG SEQADV 8E3N LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 8E3N GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 8E3N HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 8E3N GLY A 129 UNP O75469 EXPRESSION TAG SEQRES 1 A 316 MET GLY LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 316 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 316 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 316 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 316 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 316 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 316 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 316 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 316 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 316 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 316 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 316 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 316 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 316 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 316 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 316 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 316 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 316 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 316 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 316 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 316 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 316 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 316 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 316 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 316 ILE THR GLY SER HET VA0 A 501 50 HETNAM VA0 RIFAMYCIN S HETSYN VA0 (2S,12Z,14Z,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17, HETSYN 2 VA0 19-TRIHYDROXY-23-METHOXY-2,4,12,16,18,20,22- HETSYN 3 VA0 HEPTAMETHYL-1,6,9,11-TETRAOXO-1,2,6,9-TETRAHYDRO-2,7- HETSYN 4 VA0 (EPOXYPENTADECA[1,11,13]TRIENOIMINO)NAPHTHO[2,1- HETSYN 5 VA0 B]FURAN-21-YL ACETATE FORMUL 2 VA0 C37 H45 N O12 FORMUL 3 HOH *111(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ALA A 197 CYS A 207 1 11 HELIX 3 AA3 LYS A 234 SER A 238 5 5 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 THR A 290 1 23 HELIX 7 AA7 GLU A 321 LEU A 333 1 13 HELIX 8 AA8 HIS A 336 PHE A 349 1 14 HELIX 9 AA9 GLN A 358 ARG A 381 1 24 HELIX 10 AB1 GLN A 383 ARG A 387 5 5 HELIX 11 AB2 PHE A 388 HIS A 418 1 31 HELIX 12 AB3 THR A 422 PHE A 429 1 8 SHEET 1 AA1 5 VAL A 222 TYR A 225 0 SHEET 2 AA1 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 AA1 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212 SHEET 4 AA1 5 THR A 298 CYS A 301 -1 N CYS A 301 O LEU A 304 SHEET 5 AA1 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 CRYST1 91.893 91.893 85.991 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010882 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010882 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011629 0.00000